Suzuki A, Tsutomi Y, Yamamoto N, Shibutani T, Akahane K
Drug Safety Research Laboratory, Daiichi Pharmaceutical Co., Ltd., Edogawa-ku, Tokyo 134-8630, Japan.
Mol Cell Biol. 1999 May;19(5):3842-7. doi: 10.1128/MCB.19.5.3842.
Death receptor Fas transduces cell death signaling upon stimulation by Fas ligand, and this death signaling is mediated by caspase. Recently, we reported that the cell cycle regulator p21 interacts with procaspase 3 to resist Fas-mediated cell death. In the present study, the molecular characterization and functional region of the procaspase 3-p21 complex was further investigated. We observed the p21 expression in the mitochondrial fraction of HepG2 cells and detected Fas-mediated cell death only in the presence of actinomycin D. However, mitochondrial-DNA-lacking HepG2 (MDLH) cells showed this effect even in the absence of actinomycin D. Both p21 and procaspase 3 were expressed in MDLH cells, but the procaspase 3-p21 complex formation was not observed. Interestingly, the resistance to Fas-mediated cell death in the MDLH cells without actinomycin D was recovered after microinjection of HepG2-derived mitochondria into the MDLH cells. We conclude that mitochondria are necessary for procaspase 3-p21 complex formation and propose that the mitochondrial role during cell death is not only death induction but also death suppression.
死亡受体Fas在受到Fas配体刺激时转导细胞死亡信号,且这种死亡信号由半胱天冬酶介导。最近,我们报道细胞周期调节因子p21与前体半胱天冬酶3相互作用以抵抗Fas介导的细胞死亡。在本研究中,我们进一步研究了前体半胱天冬酶3-p21复合物的分子特征和功能区域。我们观察到p21在HepG2细胞的线粒体部分表达,并且仅在放线菌素D存在的情况下检测到Fas介导的细胞死亡。然而,缺乏线粒体DNA的HepG2(MDLH)细胞即使在没有放线菌素D的情况下也表现出这种效应。p21和前体半胱天冬酶3均在MDLH细胞中表达,但未观察到前体半胱天冬酶3-p21复合物的形成。有趣的是,在将HepG2来源的线粒体显微注射到MDLH细胞中后,MDLH细胞在没有放线菌素D的情况下对Fas介导的细胞死亡的抗性得以恢复。我们得出结论,线粒体对于前体半胱天冬酶3-p21复合物的形成是必需的,并提出线粒体在细胞死亡过程中的作用不仅是诱导死亡,还包括抑制死亡。